LTP
LTR PHARMA FPO [LTP]
Healthcare · ASX Small Cap
$0.4650 -3.1%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 3 consecutive scansFirst seen: 2026-03-19
Get alerts when LTP triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Volume surging at 2.5x normal while price falls — heavy selling pressure
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Sitting near support — this level has held before and could attract buyers again
- Drifting lower — down 8.8% over the last 5 days
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Adequate cash runway (7 quarters)
- Very high P/S ratio (118.0x)
- Revenue in sharp decline (-38%)
- Small-cap ($20-100M)
- Sentiment is mixed — no strong consensus either way
- Altman Z-Score distress zone (1.67 < 1.81, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- MACD crossed bearish — momentum is fading
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -38% — the top line is shrinking
Expected next for LTP
Window: 21 Oct to 4 Nov
The last 8 moved LTP -3.7% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE Application for quotation of securities - LTP
NONE LTR Expands Men's Health Portfolio with KYZATREX Pilot
NONE FY26 Results Announcement
LOW Investor Presentation
Recent ASX Announcements
| 2026-09-04 | Application for quotation of securities - LTP |
| 2026-09-02 | Investor Presentation |
| 2026-08-31 | LTR Expands Men's Health Portfolio with KYZATREX Pilot |
| 2026-08-27 | FY26 Results Announcement PRICE SENSITIVE |
| 2026-08-27 | Appendix 4G and Corporate Governance Statement |
Key Metrics
$85.4M
Market Cap
130K
Avg Volume
2.5x
Vol Ratio
$0.35 — $0.81
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-54.7%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 59% |
| L | Leader vs Laggard | laggard | RS: -14 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track LTP and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required